Antibodies Against Human and Canine IL-13RA2
Copyright © Targeted News Service 2026
2026-08-25
ALEXANDRIA, Virginia, Aug. 25 -- WAKE FOREST UNIVERSITY HEALTH SCIENCES, Winston-Salem, North Carolina has been assigned a patent (No. US 12715926 B2, initially filed April 11, 2023) developed by Waldemar Debinski, Winston-Salem, North Carolina, and Denise Mazess Herpai, Winston-Salem, North Carolina, for "Antibodies against human and canine IL-13RA2." . . .
